Ying Liu

Dr. Ying Liu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
LWLiqiang Wang
Liqiang Wang
RYRui Yang
Rui Yang
BYBochuan Yuan
Bochuan Yuan
YLYing Liu
Ying Liu
CLChunsheng Liu
Chunsheng Liu
Licorice is a common herb which has been used in traditional Chinese medicine for centuries. More than 20 triterpenoids and nearly 300 flavonoids have been isolated from licorice. Recent studies have shown that these metabolites possess many pharmacological activities, such as antiviral, antimicrobial, anti-inflammatory, antitumor and other activities. This paper provides a summary of the antiviral and antimicrobial activities of licorice. The active components and the possible mechanisms for these activities are summarized in detail. This review will be helpful for the further studies of licorice for its potential therapeutic effects as an antiviral or an antimicrobial agent.

21 September 2016 in Pharmaceutical Biology
Verified
Journal Article
Open access
RYRui Yang
Rui Yang
BYBo-Chuan Yuan
Bo-Chuan Yuan
YMYong-Sheng Ma
Yong-Sheng Ma
SZShan Zhou
Shan Zhou
YLYing Liu
Ying Liu
Context: Increasing incidence and impact of inflammatory diseases have encouraged the search of new pharmacological strategies to face them. Licorice has been used to treat inflammatory diseases since ancient times in China. Objective: To summarize the current knowledge on anti-inflammatory properties and mechanisms of compounds isolated from licorice, to introduce the traditional use, modern clinical trials and officially approved drugs, to evaluate the safety and to obtain new insights for further research of licorice. Methods: PubMed, Web of Science, Science Direct and ResearchGate were information sources for the search terms ‘licorice’, ‘licorice metabolites’, ‘anti-inflammatory’, ‘triterpenoids’, ‘flavonoids’ and their combinations, mainly from year 2010 to 2016 without language restriction. Studies were selected from Science Citation Index journals, in vitro studies with Jadad score less than 2 points and in vivo and clinical studies with experimental flaws were excluded. Results: Two hundred and ninety-five papers were searched and 93 papers were reviewed. Licorice extract, 3 triterpenes and 13 flavonoids exhibit evident anti-inflammatory properties mainly by decreasing TNF, MMPs, PGE2 and free radicals, which also explained its traditional applications in stimulating digestive system functions, eliminating phlegm, relieving coughing, nourishing qi and alleviating pain in TCM. Five hundred and fifty-four drugs containing licorice have been approved by CFDA. The side effect may due to the cortical hormone like action. Conclusion: Licorice and its natural compounds have demonstrated anti-inflammatory activities. More pharmacokinetic studies using different models with different dosages should be carried out, and the maximum tolerated dose is also critical for clinical use of licorice extract and purified compounds.

12 December 2016 in Pharmaceutical Biology
Verified
Journal Article
Open access
BYBochuan Yuan
Bochuan Yuan
RYRui Yang
Rui Yang
YMYongsheng Ma
Yongsheng Ma
SZShan Zhou
Shan Zhou
XZXiaodong Zhang
Xiaodong Zhang
YLYing Liu
Ying Liu
Context: Radix Bupleuri has been used in traditional Chinese medicine for over 2000 years with functions of relieving exterior syndrome, clearing heat, regulating liver-qi, and lifting yang-qi. More natural active compounds, especially saikosaponins, have been isolated from Radix Bupleuri, which possess various valuable pharmacological activities. Objective: To summarize the current knowledge on pharmacological activities, mechanisms and applications of extracts and saikosaponins isolated from Radix Bupleuri, and obtain new insights for further research and development of Radix Bupleuri. Methods: PubMed, Web of Science, Science Direct, Research Gate, Academic Journals and Google Scholar were used as information sources through the inclusion of the search terms ‘Radix Bupleuri’, ‘Bupleurum’, ‘saikosaponins’, ‘Radix Bupleuri preparation’, and their combinations, mainly from the year 2008 to 2016 without language restriction. Clinical preparations containing Radix Bupleuri were collected from official website of China Food and Drug Administration (CFDA). Results and conclusion: 296 papers were searched and 128 papers were reviewed. A broad spectrum of in vitro and in vivo research has proved that Radix Bupleuri extracts, saikosaponin a, saikosaponin d, saikosaponin c, and saikosaponin b2, exhibit evident anti-inflammatory, antitumor, antiviral, anti-allergic, immunoregulation, and neuroregulation activities mainly through NF-κB, MAPK or other pathways. 15 clinical preparations approved by CFDA remarkably broaden the application of Radix Bupleuri. The main side effect of Radix Bupleuri is liver damage when the dosage is excess, which indicates that the maximum tolerated dose is critical for clinical use of Radix Bupleuri extract and purified compounds.

15 October 2018 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
YYYan-Chao Yin
Yan-Chao Yin
XZXiao-Dong Zhang
Xiao-Dong Zhang
ZGZhi-Qiang Gao
Zhi-Qiang Gao
THTing Hu
Ting Hu
YLYing Liu
Ying Liu

1 March 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZZZhixin Zhang
Zhixin Zhang
LYLin Yang
Lin Yang
JHJiaming Hou
Jiaming Hou
STShaokai Tian
Shaokai Tian
YLYing Liu
Ying Liu

1 December 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LYLin Yang
Lin Yang
YJYu Jiang
Yu Jiang
ZZZhixin Zhang
Zhixin Zhang
JHJiaming Hou
Jiaming Hou
STShaokai Tian
Shaokai Tian
YLYing Liu
Ying Liu